VPHIF (Valeo Pharma) Interest Expense: $-11.28 Mil (TTM As of Jul. 2024)


VPHIF Valeo Pharma Inc VPHIF
12 GF Score
Price $0.00
View Full Analysis

What is Valeo Pharma Interest Expense?

Valeo Pharma VPHIF -99.00% 12 Interest Expense is $-11.28 Mil as of Jul. 2024. GuruFocus rates VPHIF with a GF Score™ of 12/100.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Valeo Pharma's interest expense for the three months ended in Jul. 2024 was $ -2.90 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jul. 2024 was $-11.28 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Valeo Pharma's Operating Income for the three months ended in Jul. 2024 was $ -1.88 Mil. Valeo Pharma's Interest Expense for the three months ended in Jul. 2024 was $ -2.90 Mil. Valeo Pharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Valeo Pharma  (OTCPK:VPHIF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Valeo Pharma's Interest Expense for the three months ended in Jul. 2024 was $-2.90 Mil. Its Operating Income for the three months ended in Jul. 2024 was $-1.88 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jul. 2024 was $17.82 Mil.

Valeo Pharma's Interest Coverage for the quarter that ended in Jul. 2024 is calculated as

Valeo Pharma did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Valeo Pharma Interest Expense Historical Data

* Premium members only.

The historical data trend for Valeo Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valeo Pharma Interest Expense Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Interest Expense
Get a 7-Day Free Trial -0.08 -0.45 -1.09 -4.72 -10.06

Valeo Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.61 -2.74 -2.84 -2.81 -2.90
VPHIF
12GF Score
Valeo Pharma Inc VPHIF
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valeo Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-11.28 Mil mean?
Valeo Pharma (VPHIF) has a Interest Expense of $-11.28 Mil as of Jul. 2024. Interest Expense is the amount a company pays on its long-term debt. View historical data on Valeo Pharma and its competitors.
Is Valeo Pharma's Interest Expense too high?
Valeo Pharma's current Interest Expense is $-11.28 Mil. Overall, Valeo Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Valeo Pharma's Interest Expense compare to ZTS?
Valeo Pharma's Interest Expense of $-11.28 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Valeo Pharma and its competitors. Valeo Pharma's current Interest Expense is $-11.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valeo Pharma stock overvalued right now?
Valeo Pharma (VPHIF) has a current Interest Expense of $-11.28 Mil. The current Interest Expense is $-11.28 Mil. Valeo Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Valeo Pharma (VPHIF), the current Interest Expense is $-11.28 Mil as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Valeo Pharma Business Description

Address 16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
12GF Score

Get the complete analysis for VPHIF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price